Research output per year
Research output per year
Personal profile
Research Interests
Cancer supportive and palliative care. Work around symptom management, chemotherapy-induced nausea and vomiting, chemotherapy-induced peripheral neuropathy, respiratory symptoms in lung cancer (cough and breathlessness), symptom clusters
Short Bio (max 200 characters)
Alex Molassiotis's research focuses on cancer supportive and palliative care. work around symptom management, chemotherapy-induced nausea and vomiting and chemotherapy-induced peripheral neuropathy.
Education/Academic qualification
PhD, quality of life in bone marrow transplant survivors, University of Birmingham
MSc, University of Hull
Keywords
- RT Nursing
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 2 Zero Hunger -
SDG 3 Good Health and Well-being -
SDG 10 Reduced Inequalities
Fingerprint
Dive into the research topics where Alex Molassiotis is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Looking Back, Looking Forward: Reflections on 23 Years as Editor-in-Chief of the European Journal of Oncology Nursing
Molassiotis, A., 3 Apr 2026, In: European Journal of Oncology Nursing. 81, 1 p., 103169.Research output: Contribution to journal › Editorial › peer-review
-
Multinational Association of Supportive Care in Cancer (MASCC) endorsement and global perspectives on implementation of the American Society of Clinical Oncology and Society of Integrative Oncology (ASCO-SIO) fatigue in adult cancer survivors guideline
Kleckner, A. S., Agbejule, O. A., Al-Harrasi, A., Escalante, C. P., Keane, P., Lin, P. J., Molassiotis, A., Mustian, K. M., Potter, L., Prue, G., Singh Uppal, R., Whitehead, M. & Hart, N. H., 10 Jun 2026, In: Supportive Care in Cancer. 34, 5 p., 638.Research output: Contribution to journal › Editorial › peer-review
-
Oncology nursing at an inflection point: Five imperatives for the next five years
Molassiotis, A. & Tan, J.-Y. B., Aug 2026, In: European Journal of Oncology Nursing. 83, 3 p., 103236.Research output: Contribution to journal › Editorial
-
Personalised antiemetic prophylaxis with NEPA for patients at high risk of chemotherapy-induced nausea and vomiting receiving moderately emetogenic chemotherapy: results from the randomised, multinational MyRisk trial
Molassiotis, A., Jordan, K., Karthaus, M., Dranitsaris, G., Roeland, E. J., Schwartzberg, L., Stimamiglio, V., Alonzi, A., Olivari Tilola, S., Bonizzoni, E., Brozos Vázquez, E., Buchler, T., Cheng, Y., Christoph, D. C., García Alfonso, P., Lu, X., Majem, M., Mavroudis, D., Syrigos, K. & Tomlins, E. & 3 others, , 1 Feb 2026, In: Annals of Oncology. 37, 2, p. 260-270 11 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile -
Understanding the factors influencing quality of life among survivors of Non-Hodgkin lymphoma after completing primary treatment: a systematic review
Lekdamrongkul, P., Ruksakulpiwat, S., Tadsuan, J., Pongthavornkamol, K. & Molassiotis, A., 3 Mar 2026, In: Supportive Care in Cancer. 34, 3, 13 p., 266.Research output: Contribution to journal › Review article › peer-review
Open AccessFile